title: Globus pharyngeus: effectiveness of treatment with proton pump inhibitors and gabapentin.
abstract: OBJECTIVE
  This study was performed to investigate the effectiveness of treatment of globus pharyngeus with proton pump inhibitors, gabapentin, or both.
  
  
  METHODS
  The subjects all presented with globus pharyngeus during the years 2006 to 2011. The inclusion criteria included a chief (primary) complaint of globus pharyngeus; a trial of proton pump inhibitor therapy for at least 2 months and/or a trial of gabapentin for at least 2 weeks; and at least 1 follow-up visit. We reviewed 331 charts; 87 patients met the criteria. The response to treatment was graded as none, partial, or complete.
  
  
  RESULTS
  Seventy-seven percent of all patients had improvement. Sixty-seven percent of patients had a partial or complete response from aggressive reflux management. Sixty-six percent of patients who had a trial of gabapentin reported improvement. Eight of 14 patients who did not improve with aggressive reflux management improved with gabapentin.
  
  
  CONCLUSIONS
  A majority of patients with globus pharyngeus can be helped by treating reflux or neuralgia. A trial of gabapentin should be considered for patients who do not respond or only partially respond to reflux management.
authors.affiliation: Lakeshore Ear, Nose and Throat Center, 21000 E 12 Mile Rd, Ste 111, St Clair Shores, MI 48081, USA.
authors.forename: Suzanne
authors.initials: S
authors.lastname: Kirch
authors.forename: Ryan
authors.initials: R
authors.lastname: Gegg
authors.forename: Michael M
authors.initials: MM
authors.lastname: Johns
authors.forename: Adam D
authors.initials: AD
authors.lastname: Rubin
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000588:Amines / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000188:drug therapy*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D008297:Male; D008875:Middle Aged; D010612:Pharyngitis / Q000188:drug therapy*; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies; D012678:Sensation Disorders / Q000188:drug therapy*; D016896:Treatment Outcome; D055815:Young Adult; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000588:Amines; D000700:Analgesics; D003509:Cyclohexanecarboxylic Acids; D054328:Proton Pump Inhibitors; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin